TAAV

TAAV-firma

Leading player in the production of synthetic DNA used in gene therapy.

Touchlight Adeno Asociated Virus manufactures advanced gene therapy solutions by offering its synthetic, linear, double-stranded DNA as the new industry standard for transfection-based adeno-associated virus (AAV) production. A safer, more efficient, scalable and faster way to manufacture AAVs.

CEO: Alfredo Martínez.

DIVESTED COMPANY
2018-2019 (Sold to Askbio)

Details

TAAV
Parque Científico y Tecnológico de Gipuzkoa
Paseo Mikeletegi, 73 B.

20009 – San Sebastián (Gipuzkoa)

News